 |
Kosan, Roche initiate clinical trial of KOS-1584, next generation epothilone
Friday, December 10, 2004 09:00 IST
Hayward, California
Kosan Biosciences Incorporated has initiated a phase I clinical trial evaluating KOS-1584 (9,10-didehydroepothilone D), a second-generation epothilone
Read complete story ...
(You will need to login first to read this story.)
|
|
|
